SEC Form 4/A · accession 0001162194-18-000052
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steven McPhail
Officer — Chief Commercial Officer
Period of report
Sep 20, 2017
Accepted (ET)
Apr 3, 2018 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2,F1 | $25.23 | Sep 20, 2017 | D | 31,000 | D | — | May 21, 2025 | Common Stock | 31,000 | 0 | D |
| Employee Stock Option (Right to Buy)F2,F3 | $5.13 | Sep 20, 2017 | A | 7,127 | A | — | Sep 20, 2027 | Common Stock | 7,127 | 7,127 | D |
| Employee Stock Option (Right to Buy)F5,F4 | $7.10 | Sep 20, 2017 | D | 13,500 | D | — | Mar 4, 2026 | Common Stock | 13,500 | 0 | D |
| Employee Stock Option (Right to Buy)F5,F3,F6 | $5.13 | Sep 20, 2017 | A | 8,941 | A | — | — | Common Stock | 8,941 | 8,941 | D |
| Employee Stock Option (Right to Buy)F8,F7 | $6.16 | Sep 20, 2017 | D | 51,375 | D | — | Feb 13, 2027 | Common Stock | 51,375 | 0 | D |
| Employee Stock Option (Right to Buy)F8,F3,F6 | $5.13 | Sep 20, 2017 | A | 36,697 | A | — | — | Common Stock | 36,697 | 36,697 | D |
| Employee Stock Option (Right to Buy)F9,F4 | $7.10 | Sep 20, 2017 | D | 6,750 | D | — | Mar 4, 2026 | Common Stock | 6,750 | 0 | D |
| Employee Stock Option (Right to Buy)F9,F3,F6 | $5.13 | Sep 20, 2017 | A | 4,471 | A | — | — | Common Stock | 4,471 | 4,471 | D |
Explanation of responses
- F1The Option provided for vesting of 12/48th of the total number of shares subject to the Option on May 7, 2016 and thirty-six equal monthly installments beginning on June 7, 2017.
- F2On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 31,000 shares of FLDM common stock granted to the Reporting Person on May 21, 2015. In exchange, the Reporting Person received a replacement Option, for 7,127 shares, having an exercise price of $5.13 per share.
- F31/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
- F4The Option provided for vesting in forty-eight equal monthly installments beginning on February 1, 2016.
- F5On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,500 shares of FLDM common stock granted to the Reporting Person on March 4, 2016. In exchange, the Reporting Person received a replacement Option, for 8,941 shares, having an exercise price of $5.13 per share.
- F6The Option expiration date is September 20, 2027.
- F7The Option provided for vesting in forty-eight equal monthly installments beginning on February 1, 2017.
- F8On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 51,375 shares of FLDM common stock granted to the Reporting Person on February 13, 2017. In exchange, the Reporting Person received a replacement Option, for 36,697 shares, having an exercise price of $5.13 per share.
- F9On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 6,750 shares of FLDM common stock granted to the Reporting Person on March 4, 2016. In exchange, the Reporting Person received a replacement Option, for 4,471 shares, having an exercise price of $5.13 per share.